Latest / Decera Clinical Education Oncology Podcast
Expert Answers to HCP Questions on CAR T-Cell Therapy
In this episode, Caron A. Jacobson, MD; Jae H. Park, MD; and Noopur Raje, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in CAR T-cell therapy, with questions including:
At what time in the treatment journey should CAR T-cell therapy be considered?
How to select among 3 approved products for relapsed/refractory large B-cell lymphoma?
How is CAR T-cell therapy best used for multiple myeloma?
What qualities of bridging therapy are most preferred?
When do patients receiving CAR T-cell therapy need COVID-19 or other vaccinations?…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.